Transcriptome based differentiation of harmless, teratogenetic and cytotoxic concentration ranges of valproic acid.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-ToxArchives of toxicology · 2017
   Article
2. Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling.EXCLI journal · 2015
   Article
3. Highlight report: Erroneous sample annotation in a high fraction of publicly available genome-wide expression datasets.EXCLI journal · 2015
   Article
4. Highlight report: New methods for quantification of bile canalicular dynamics.EXCLI journal · 2015
   Article
5. Expression classifiers for developmental toxicants.EXCLI journal · 2015
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.